News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
236,149 Results
Type
Article (8899)
Company Profile (84)
Press Release (227164)
Multimedia
Podcasts (89)
Webinars (17)
Section
Business (79059)
Career Advice (390)
Deals (13159)
Drug Delivery (40)
Drug Development (36785)
Employer Resources (76)
FDA (4281)
Job Trends (4806)
News (122151)
Policy (9430)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (347)
Accelerated approval (22)
ADA (13)
Adcomms (5)
Allergies (79)
Alliances (18092)
ALS (87)
Alzheimer's disease (678)
Antibody-drug conjugate (ADC) (302)
Approvals (4632)
Artificial intelligence (269)
ASCO (128)
Autoimmune disease (177)
Automation (18)
Bankruptcy (70)
Best Places to Work (3598)
BIO (40)
BIOSECURE Act (16)
Biosimilars (167)
Biotechnology (55)
Bladder cancer (82)
Brain cancer (31)
Breast cancer (241)
Cancer (2446)
Cardiovascular disease (151)
Career advice (372)
Career pathing (39)
CAR-T (132)
CDC (15)
Celiac Disease (1)
Cell therapy (337)
Cervical cancer (19)
Clinical research (33880)
Collaboration (1015)
Commercialization (3)
Compensation (895)
Complete response letters (47)
COVID-19 (833)
CRISPR (35)
C-suite (629)
Cystic fibrosis (49)
Data (3807)
Decentralized trials (1)
Denatured (14)
Depression (92)
Dermatology (42)
Diabetes (190)
Diagnostics (1267)
Digital health (13)
Diversity (7)
Diversity, equity & inclusion (19)
Drug discovery (136)
Drug pricing (62)
Drug shortages (4)
Duchenne muscular dystrophy (130)
Earnings (30558)
Editorial (51)
Employer branding (10)
Employer resources (67)
Events (42478)
Executive appointments (563)
FDA (5992)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (2)
Frontotemporal dementia (10)
Funding (668)
Gene editing (74)
Generative AI (25)
Gene therapy (229)
GLP-1 (411)
Government (1033)
Grass and pollen (1)
Guidances (165)
Healthcare (3281)
Hematology (82)
HIV (43)
Huntington's disease (16)
IgA nephropathy (50)
Immunology and inflammation (109)
Immuno-oncology (53)
Indications (109)
Infectious disease (952)
Inflammatory bowel disease (101)
Inflation Reduction Act (8)
Influenza (41)
Intellectual property (138)
Interviews (68)
IPO (6860)
IRA (18)
Job creations (1206)
Job search strategy (275)
JPM (37)
Kidney cancer (16)
Labor market (103)
Layoffs (199)
Leadership (38)
Legal (1719)
Liver cancer (39)
Longevity (8)
Lung cancer (412)
Lymphoma (212)
Machine learning (25)
Management (25)
Manufacturing (520)
Marketing (7)
MASH (142)
Medical device (1555)
Medtech (1579)
Mergers & acquisitions (7018)
Metabolic disorders (646)
mRNA (75)
Multiple sclerosis (93)
NASH (8)
Neurodegenerative disease (165)
Neuropsychiatric disorders (53)
Neuroscience (1381)
NextGen: Class of 2026 (1158)
Non-profit (303)
Now hiring (65)
Obesity (287)
Opinion (130)
Ovarian cancer (79)
Pain (86)
Pancreatic cancer (102)
Parkinson's disease (141)
Partnered (8)
Patents (253)
Patient recruitment (362)
Peanut (23)
People (21655)
Pharmaceutical (29)
Pharmacy benefit managers (7)
Phase 1 (10101)
Phase 2 (15279)
Phase 3 (11536)
Pipeline (4616)
Policy (155)
Postmarket research (699)
Preclinical (3769)
Press Release (21)
Prostate cancer (111)
Psychedelics (25)
Radiopharmaceuticals (167)
Rare diseases (489)
Real estate (1642)
Recruiting (35)
Regulatory (9138)
Reports (37)
Research institute (378)
Resumes & cover letters (45)
Rett syndrome (1)
RNA editing (9)
RSV (33)
Schizophrenia (135)
Series A (126)
Series B (87)
Service/supplier (3)
Sickle cell disease (44)
Special edition (26)
Spinal muscular atrophy (55)
Sponsored (8)
Startups (1267)
State (1)
Stomach cancer (4)
Supply chain (43)
Tariffs (48)
The Weekly (74)
Vaccines (321)
Venture capital (73)
Weight loss (135)
Women's health (35)
Worklife (18)
Date
Today (51)
Last 7 days (213)
Last 30 days (789)
Last 365 days (12837)
2026 (7363)
2025 (12699)
2024 (14515)
2023 (16660)
2022 (21155)
2021 (22274)
2020 (19273)
2019 (12562)
2018 (9184)
2017 (11313)
2016 (9514)
2015 (12203)
2014 (9320)
2013 (7092)
2012 (7079)
2011 (7095)
2010 (6874)
Location
Africa (230)
Alabama (25)
Arizona (52)
Arkansas (3)
Asia (29736)
Australia (3727)
California (5852)
Canada (1360)
China (1245)
Colorado (208)
Connecticut (262)
Delaware (252)
Europe (36032)
Florida (829)
Georgia (166)
Hawaii (1)
Idaho (3)
Illinois (340)
India (64)
Indiana (209)
Iowa (15)
Japan (456)
Kansas (83)
Kentucky (12)
Louisiana (5)
Maine (6)
Maryland (594)
Massachusetts (4710)
Michigan (59)
Minnesota (205)
Mississippi (2)
Missouri (36)
Montana (2)
Nebraska (8)
Nevada (31)
New Hampshire (9)
New Jersey (2005)
New Mexico (7)
New York (1796)
North Carolina (743)
Northern California (3106)
Ohio (139)
Oklahoma (9)
Oregon (13)
Pennsylvania (1044)
Puerto Rico (16)
Rhode Island (12)
South America (285)
South Carolina (7)
Southern California (2314)
Tennessee (29)
Texas (654)
United States (20467)
Utah (134)
Vermont (1)
Virginia (179)
Washington D.C. (25)
Washington State (392)
West Virginia (1)
Wisconsin (29)
236,149 Results for "redhill biopharma ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Propanc Biopharma Signs MOU with Avance Clinical Pty Ltd
July 7, 2026
·
5 min read
Job Trends
Report: Biopharma Job Market Report Q2 2026
Gain the latest insights into the biopharma hiring landscape with BioSpace’s Biopharma Job Market Report Q2 2026. Explore the trends shaping talent acquisition, from rising job postings and sustained R&D hiring to the market activity signaling stronger hiring demand ahead.
July 13, 2026
·
1 min read
·
BioSpace Insights
Career Advice
The top 12 companies hiring in biopharma now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
July 2, 2026
·
1 min read
·
Angela Gabriel
SUPPORTED BY AMPLITY
Webinar: From Clinical to Commercial: Talent Strategies for Biopharma Growth
This webinar provides an assessment of recent job market activity across biopharma and explores how companies approaching commercial readiness or building out sales and marketing teams can navigate today’s hiring trends.
July 22, 2026
·
1 min read
·
BioSpace Insights
Artificial intelligence
Biopharma R&D needs ‘structural redesign’ to maximize AI impact: report
Biopharma companies won’t fully capture the benefits of AI unless they reorganize their R&D units, according to McKinsey.
July 9, 2026
·
2 min read
·
Nick Paul Taylor
Job Trends
Biopharma layoffs must double in H2 for 2026 to match 2025 cuts
With fewer biopharmas making or planning workforce reductions so far year over year, layoff round size and M&A impact on headcounts will likely shape the number of employees who are ultimately on the chopping block.
July 23, 2026
·
4 min read
·
Angela Gabriel
Podcast
Moderna’s FDA adcomm, IPO mania, biopharma layoffs, more
Moderna appears to have aligned with the FDA ahead of an advisory committee meeting for its mRNA-based flu vaccine, which the regulator initially turned away in February; biotech IPOs are going gangbusters, including two new records raises in as many weeks; layoffs continue across biopharma; plus much more.
June 17, 2026
·
2 min read
·
Jef Akst
Press Releases
Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody
April 30, 2026
·
9 min read
Deals
RedHill Biopharma Announces $8 Million Registered Direct Offering
RedHill Biopharma Ltd. investors for the purchase and sale of 10,000,000 of the Company’s American Depositary Shares (“ADSs”) at a purchase price of $0.80 per ADS, in a registered direct offering.
January 25, 2024
·
9 min read
Press Releases
Quantum BioPharma Ltd. Announces Corporate Updates
October 30, 2025
·
11 min read
1 of 23,615
Next
